Cervical Cancer Gap Will Widen without Urgent Global Action
A new Lancet modelling study warns that without accelerated HPV vaccination and screening, cervical‑cancer disparities between low‑ and middle‑income countries (LMICs) and high‑income countries (HICs) will widen dramatically. Currently only 10% of women in LMICs are screened and 23% of girls are vaccinated, compared with 84% and 57% respectively in HICs. Achieving the WHO targets of 90% vaccination, 70% screening and 90% treatment, especially when combined with universal multi‑cohort vaccination, could eliminate cervical cancer globally by 2070 and prevent up to 37 million cases. In contrast, relying on vaccination alone would leave LMICs trailing HICs by decades and could temporarily increase inequality.
Exercise Physiologists Demand an End to 'Discriminatory' Health Tax
Exercise and Sports Science Australia (ESSA) has launched an "axe the tax" campaign to eliminate the 10% Goods and Services Tax (GST) applied to exercise physiology services, a levy that other allied health professions do not face. The peak body...
Beyond Telesurgery: How Proximie Uses AI to Optimise Surgery Logistics
Proximie, an AWS‑partner, is turning operating‑room logistics into a data‑driven system by deploying ceiling‑mounted computer‑vision sensors and a hybrid edge‑to‑cloud architecture that handles 120 TB of video. The platform uses generative AI to predict procedure duration, enabling hospitals like St Thomas’ to...
Furin‐Mediated Intracellular Aggregation of Radioactive Molecules for Enhanced Radionuclide Imaging and Tumor Therapy
Researchers have engineered a furin‑responsive radioactive probe, RVRR‑TPE, that self‑assembles into nanoparticles inside furin‑positive cancer cells. The molecule couples a furin‑cleavable Arg‑Val‑Arg‑Arg peptide, an aggregation‑induced emission fluorophore (tetraphenylethene), and a phenol group for iodine‑125/131 labeling. In mouse models, the 125I/131I‑labeled...
Caris Launches Caris MI Clarity for AI-Powered Breast Cancer Recurrence Risk Assessment
Caris Life Sciences has introduced Caris MI Clarity, an AI‑driven prognostic test that evaluates both early (0‑5 years) and late (5‑15 years) distant recurrence risk for postmenopausal patients with HR‑positive/HER2‑negative, node‑negative early‑stage breast cancer. The assay analyzes digitized H&E pathology...
Hierarchically Multifunctional Fiber‐optic Theranostic Probe for Cancer Photothermal‐photodynamic Synergism
Researchers have created a hierarchically multifunctional fiber‑optic probe that simultaneously measures dissolved oxygen and delivers combined photothermal‑photodynamic therapy. The three‑layer architecture isolates an Ru(dpp) oxygen sensor, an ICG photosensitizer, and a CaO2@LA oxygen‑generating layer, eliminating optical crosstalk and counteracting tumor...
UN Experts Condemn Attacks on Sudan Healthcare System
UN experts condemned the relentless attacks on Sudan’s hospitals and medical staff, citing 217 incidents since April 2025, including a March 20 strike on Al Deain Teaching Hospital that left 64 injured, 13 of them children. They warned that the...
The Effects of Ketogenic Diet and Calorie-Restricted Diet on Metabolic Dysfunction-Associated Steatotic Liver Disease: A Retrospective Study
A retrospective cohort of 102 MASLD patients compared a 12‑week ketogenic diet (KD) with a calorie‑restricted diet (CRD). The KD produced a markedly larger drop in hepatic steatosis, with median CAP reduction of 62 dB/m versus 36 dB/m for CRD, and 84%...
Pre-Existing Iron Deficiency Anemia and Long-Term Risk of Recurrent Acute Kidney Injury in Survivors of ICU-Associated AKI: A Propensity-Matched Study
A large propensity‑score‑matched study of 13,002 ICU patients with acute kidney injury (AKI) found that pre‑existing iron deficiency anemia (IDA) markedly raises the risk of recurrent AKI (rAKI) over the next three years. The hazard ratio for rAKI was 1.53,...
GLP-1s: Is the Industry Asking the Wrong Question?
GLP‑1 medications now reach roughly 13.3% of U.S. consumers and could climb to about 21% by 2030, prompting a reevaluation of food‑category impacts. Industry research from the American Bakers Association shows that rather than abandoning baked‑goods, users are eating smaller...
Hong Kong Reviews Safeguards for Shared Use of Elderly Health Care Vouchers
Hong Kong’s Department of Health is tightening controls on the Elderly Health Care Voucher (EHCV) scheme after discovering misuse of vouchers belonging to deceased spouses. Since July 2023, more than 178,000 elderly couples have linked accounts, generating over 670,000 shared...
Multi4 Medical Receives CE Mark Approval for Multi4 System to Perform Outpatient Bladder Cancer Treatment
Multi4 Medical has secured CE mark approval for its Multi4 System, an integrated endoscopic platform that enables bladder cancer treatment in a single outpatient visit. The device delivers local anesthesia, performs tumor resection, extracts tissue for pathology, and cauterizes—all without...
Hamilton Medical Selects PTC Codebeamer ALM
Hamilton Medical has selected PTC’s Codebeamer Application Lifecycle Management (ALM) platform to replace its legacy system and paper‑based processes. The new solution will integrate with PTC’s Windchill PLM to provide a unified product data foundation, enabling automated traceability, audit readiness,...
What’s Next for Cervical Spine Tech and Startup Synergy Spine Solutions
Synergy Spine Solutions received FDA pre‑market clearance for its Synergy Disc, a cervical artificial disc that mimics a ball‑and‑socket hip joint to improve spinal alignment while preserving full range of motion. The implant uses a patented geometry and is offered...
Doctolib Plans for £100m UK Investment Into Digital Primary Care Acquiring Medicus
Doctolib announced a £100 million (≈$125 million) investment to acquire UK digital‑health firm Medicus, creating a 150‑person R&D centre in London. The partnership will combine Medicus’s NHS primary‑care expertise with Doctolib’s AI platform, which already serves over 40,000 European GPs. The move...
Opera Singer Who Hid Deafness for 30 Years Hails ‘Life-Changing’ Surgery
London mezzo‑soprano Janine Roebuck, 72, underwent bilateral cochlear‑implant surgery after privately funding a second implant, describing the outcome as "life‑changing." The procedure is part of a NIHR‑backed trial comparing one versus two implants in more than 250 adult NHS patients. Current...
2026 World Pediatrics Conference | October 05-06 | Osaka, Japan
The 2026 World Pediatrics Conference (2026WPC) will take place in Osaka, Japan on October 5‑6, 2026. The two‑day event gathers pediatricians, nurses, researchers and industry professionals to present the latest findings across a broad spectrum of specialties. Sessions will address neonatal care,...
Popular GLP-1 Drugs Significantly Reduce Major Cardiovascular Events,
A systematic review and meta‑analysis of eleven cardiovascular outcome trials involving 91,490 high‑risk patients found that GLP‑1 receptor agonists reduce major adverse cardiovascular events (MACE) by 14% compared with placebo. The therapy also lowered cardiovascular mortality by 13% and improved...
Power, Policy, and Public Health in South Asia: A Narrative Review with Emphasis on Pakistan
The paper reviews how political factors shape health outcomes in South Asia, focusing on Pakistan. It highlights that governance weaknesses, corruption, and the post‑18th Constitutional Amendment fragmentation impede health‑system performance. Despite successes from the Sehat Sahulat insurance scheme and the...
Digital Approach Needed for Patient Flow
A new Public Policy Projects report argues that NHS patient‑flow problems stem from governance failures rather than technology gaps. It calls for whole‑system digital intelligence paired with redesigned workflows, clear accountability, and cultural change. The paper proposes four recommendations, including...
Need to See a Psychologist? How to Find One That’s Right for You
In Australia, a GP can refer a patient to a psychologist under a mental health treatment plan, unlocking Medicare rebates for up to ten sessions a year. The referral does not lock the patient into a specific practitioner, allowing them...
Bacteria: Unsung Players in the Tumor Microbiome
Recent consensus research highlights that every tumor harbors its own low‑biomass microbiome, influencing cancer development, metastasis, and treatment response. Researchers, led by Maria Rescigno, emphasize the need for rigorous detection methods—favoring 16S rRNA sequencing and culturomics—to distinguish genuine microbes from...
Wellness Briefing: Ritual Calls on Consumers to Pressure DC Lawmakers Towards Supplement Regulation Reform, Plus News
Ritual’s new “We’re expecting” campaign asks consumers to pressure Washington lawmakers to tighten supplement regulation, targeting heavy‑metal contamination and unverified clinical‑testing claims. The company’s CEO Kat Schneider and chief impact officer Lindsay Dahl highlighted the push as part of a...
The Hidden Data Discovery Problem Inside Modern Healthcare Enterprises
Healthcare enterprises are hitting a hidden bottleneck: finding and trusting the right data before any analytics or AI work can begin. Avinash Maddineni notes that teams often spend one to two weeks digging through stale catalogs and manually tracing lineage,...
World's First Vaccine for Lyme Disease Could Be Available in 2027
Pfizer and French partner Valneva announced that their Lyme disease vaccine candidate PF‑07307405 (LB6V) achieved 73.2% efficacy in Phase III trials involving more than 9,000 participants. Although the study missed its primary statistical endpoint due to a low incidence of cases,...
The Healthcare Investment That’s Right Under Our Noses
The article argues that poor indoor air quality (IAQ) is a hidden health crisis in Australia, worsening chronic diseases, spreading infections, and reducing productivity across schools, workplaces, hospitals and homes. It highlights that one‑in‑two Australians live with chronic conditions, making...
Infoway Fires Michael Green Amid E-Prescribe Fiasco
Canada Health Infoway’s board abruptly terminated CEO Michael Green after the PrescribeIT e‑prescribing platform collapsed, despite receiving roughly US$220 million in federal funding. Launched in 2017 to replace faxed prescriptions, the system saw less than 5 % adoption and is slated to...
Southlake Offers New Model of Care with Satellite Facilities
Southlake Health has issued a request for expressions of interest to develop an advanced care centre in Georgina, part of its newly endorsed Distributed Health Network (DHN) vision. The DHN will add community‑based facilities to two existing hospitals, aiming to...
Quebec May Not Standardize on Epic Province-Wide
Quebec’s health ministry has halted plans to adopt Epic Systems for a province‑wide electronic health record, citing soaring costs and privacy worries. The two pilot projects slated for May 9 now cost roughly $298 million USD, up from an initial $196 million...
GenAI Already a Major Component of Care Delivery
A CSA Group report authored by Will Falk argues that Canada must accelerate supervised adoption of generative AI in healthcare. The paper cites current clinician use for documentation and patient‑facing tools for explanation and navigation. It warns that delaying implementation...
Winner Announced for Cancer Screening Challenge
MaRS Discovery District and the Canadian Cancer Society announced Gateway Centre of Excellence in Rural Health as the grand‑prize winner of the Rural and Remote Community Cancer Screening Challenge. The Ontario‑based nonprofit received a $100,000 prize (≈US$73,000) to expand its...
EyePoint Inc (EYPT) Q1 2026 Earnings Call Transcript
EyePoint Pharmaceuticals reported a dramatic revenue drop to $600,000 for the quarter, reflecting the reversal of deferred YUTIQ license revenue, while operating expenses surged to $71 million as Phase 3 trials for its DuraVu platform intensified. The company posted a net loss...
Vanda Pharmaceuticals Inc (VNDA) Q1 2026 Earnings Call Transcript
Vanda Pharmaceuticals reported Q1 2026 net product sales of $51.7 million, a modest 3% year‑over‑year increase driven primarily by a 26% surge in Fanapt revenue and a 32% rise in prescriptions. Hetlioz sales continued to decline, falling 24% YoY amid generic...
Taysha Gene Therapies Inc (TSHA) Q1 2026 Earnings Call Transcript
Taysha Gene Therapies announced that its Rett syndrome gene therapy TSHA-102 has moved into pivotal development, securing FDA Breakthrough Therapy designation and written alignment on both the REVEAL pivotal and ASPIRE trial designs. Early Phase 1/2 data showed a 100%...
Urogen Pharma Ltd (URGN) Q1 2026 Earnings Call Transcript
UroGen Pharma reported a $15.8 million 2025 revenue for its newly launched Zasturi, with the permanent J code effective Jan. 1 2026 spurring a sharp uptick in prescriber and site adoption. The company now has 838 activated sites, over 95% payer access, and...
Sarepta Therapeutics Inc (SRPT) Q1 2026 Earnings Call Transcript
Sarepta Therapeutics reported $1.86 billion net product revenue for 2025, a 16% increase, and ended the year with $954 million in cash and investments. Management guided 2026 net product revenue to $1.2‑$1.4 billion, emphasizing a low‑end outlook while targeting operating profit and positive...
Establishment Labs Holdings Inc (ESTA) Q1 2026 Earnings Call Transcript
Establishment Labs Holdings posted $53.8 million revenue in Q1 2026, a 33.7% year‑over‑year increase, and achieved a 70.1% gross profit margin, surpassing the 70% threshold for the first time. Adjusted EBITDA turned positive at $1.2 million, marking the company’s inaugural profitable quarter after...
Madrigal Pharmaceuticals Inc (MDGL) Q1 2026 Earnings Call Transcript
Madrigal Pharmaceuticals reported its Q1 2026 earnings, highlighting that Rezdiffra generated $958 million in net sales for its first full year, nearly $1 billion in total revenue. Patient enrollment rose to 36,250, reflecting strong sequential growth in the expanding MASH market. The...
Biote Corp (BTMD) Q1 2026 Earnings Call Transcript
Biote Corp reported Q1 2026 revenue of $46.4 million, down 6.9% year‑over‑year, with procedure revenue falling 13% while dietary supplement sales jumped 16% driven by e‑commerce. Gross profit margin slipped to 68% after a $1.3 million inventory charge linked to...
Novavax Inc (NVAX) Q1 2026 Earnings Call Transcript
Novavax reported a Q1 2019 net loss of $43.2 million, improving from the prior year, while revenue fell 59% to $4 million as the Bill & Melinda Gates Foundation grant wound down. The company highlighted clinical milestones for its RSV vaccine ResVax,...
Bioventus Inc (BVS) Q1 2026 Earnings Call Transcript
Bioventus Inc. reported Q1 2026 revenue of $158 million, a 3% year‑over‑year increase and 10% organic growth, driven primarily by volume gains in its Pain Treatments and Restorative Therapies segments. Adjusted EBITDA rose 30% to $37 million, expanding the margin to 23%...
Sera Prognostics Inc (SERA) Q1 2026 Earnings Call Transcript
Sera Prognostics reported Q1 2026 revenue of $14 k, down from $38 k, while operating expenses rose slightly to $9.4 M, resulting in an $8.4 M net loss. Management highlighted a strategic shift from R&D to commercialization, launching a third partnership program that reaches...
Agilon Health Inc (AGL) Q1 2026 Earnings Call Transcript
Agilon Health reported Q1 2026 revenue of $1.42 billion, down from a year earlier, as Medicare Advantage and ACO REACH memberships slipped to 426,000 and 110,000 respectively. Despite the headcount decline, medical margin rose to $149 million and adjusted EBITDA more than doubled...
Zevra Therapeutics Inc (ZVRA) Q1 2026 Earnings Call Transcript
Zevra Therapeutics reported Q1 2026 net revenue of $36.2 million, a 78% year‑over‑year increase, driven primarily by MyPlifer sales of $24.6 million and a $10.2 million expanded‑access program. The company completed the $50 million divestiture of its SDX portfolio, recorded a $43.3 million one‑time gain...
Mineralys Therapeutics Inc (MLYS) Q1 2026 Earnings Call Transcript
Mineralys Therapeutics reported Q1 2026 results highlighting FDA acceptance of lorundrostat’s NDA with a PDUFA target of Dec 22, 2026. The company completed five trials showing durable blood‑pressure reductions, though the EXPLORER‑OSA study missed its primary AHI endpoint, it still demonstrated a...
Cytokinetics Scores Late-Stage Win in Non-Obstructive HCM as BMS Plans Camzyos Restart
Cytokinetics announced that its experimental drug Myqorzo (aficamten) achieved both primary endpoints in the Phase III ACACIA‑HCM trial, marking the first late‑stage success for a therapy targeting non‑obstructive hypertrophic cardiomyopathy (HCM). The result propelled the company’s stock up 17%, pushing its...
Re: The UK Covid-19 Inquiry Lays Bare the Cost of Delayed Action for NHS Staff
The UK Covid‑19 Inquiry highlighted stark disparities in pandemic outcomes for NHS and social‑care staff. By April 2020, two‑thirds of the 106 healthcare workers who died were from Black, Asian and Minority Ethnic (BAME) backgrounds, even though they represent only 20.7%...
Pursuing Tech-Enabled Preventive Healthcare for Lower-Income Families
National University Hospital’s HEADS‑UPP programme in Singapore is using tele‑dentistry to deliver preventive dental care to low‑income preschoolers. Nurses capture intra‑oral images at preschools, which paediatric dentists review remotely to produce personalized risk reports. Early data show follow‑up specialist care...
Both Very Low and Very High Heart Rates May Be Linked to Higher Stroke Risk, Study Says
A UK Biobank analysis of nearly 460,000 adults presented at the European Stroke Organisation Conference found a U‑shaped relationship between resting heart rate and stroke risk. The lowest risk occurred at 60‑69 beats per minute, while rates below 50 bpm...
NHI May Sell More Nursing Home Assets, Open to Offers Above Operating Partner’s $560M Pending Deal
National Health Investors (NHI) is accelerating its exit from skilled nursing facilities, highlighted by a pending $560 million sale of 32 nursing homes and three independent‑living sites to operator National HealthCare Corp. The REIT is also open to higher written offers...